JP2017214410A5 - - Google Patents

Download PDF

Info

Publication number
JP2017214410A5
JP2017214410A5 JP2017135811A JP2017135811A JP2017214410A5 JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5 JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5
Authority
JP
Japan
Prior art keywords
thiophen
biphenyl
ethoxy
carbonyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017135811A
Other languages
English (en)
Japanese (ja)
Other versions
JP6414286B2 (ja
JP2017214410A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017214410A publication Critical patent/JP2017214410A/ja
Publication of JP2017214410A5 publication Critical patent/JP2017214410A5/ja
Application granted granted Critical
Publication of JP6414286B2 publication Critical patent/JP6414286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017135811A 2012-12-28 2017-07-11 ハロゲン置換へテロ環化合物 Active JP6414286B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012286425 2012-12-28
JP2012286425 2012-12-28
JP2013097171 2013-05-02
JP2013097171 2013-05-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014554626A Division JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018188246A Division JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Publications (3)

Publication Number Publication Date
JP2017214410A JP2017214410A (ja) 2017-12-07
JP2017214410A5 true JP2017214410A5 (https=) 2018-02-08
JP6414286B2 JP6414286B2 (ja) 2018-10-31

Family

ID=51021433

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014554626A Active JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物
JP2017135811A Active JP6414286B2 (ja) 2012-12-28 2017-07-11 ハロゲン置換へテロ環化合物
JP2018188246A Active JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014554626A Active JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018188246A Active JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Country Status (13)

Country Link
US (2) US10000463B2 (https=)
EP (2) EP2940013B1 (https=)
JP (3) JP6176258B2 (https=)
KR (1) KR102189166B1 (https=)
CN (2) CN104884447B (https=)
AU (1) AU2013366898B2 (https=)
BR (1) BR112015015275B1 (https=)
CA (1) CA2896701C (https=)
DK (2) DK3360869T3 (https=)
ES (2) ES2667798T3 (https=)
MX (1) MX369801B (https=)
RU (2) RU2756506C2 (https=)
WO (1) WO2014104372A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102189166B1 (ko) * 2012-12-28 2020-12-09 우베 고산 가부시키가이샤 할로겐 치환 헤테로환 화합물
WO2014145873A2 (en) 2013-03-15 2014-09-18 Epigen Biosciences, Inc. Heterocyclic compounds useful in the treatment of disease
JP2014231508A (ja) * 2013-05-02 2014-12-11 宇部興産株式会社 ハロゲン置換へテロ環化合物
RU2689315C2 (ru) * 2014-06-27 2019-05-27 Убе Индастриз, Лтд. Соль гетероциклического соединения, замещенного галогеном
EP3378491A4 (en) * 2015-11-20 2019-07-17 UBE Industries, Ltd. PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF NASH
PH12022550225A1 (en) 2019-07-30 2022-12-19 Taisho Pharmaceutical Co Ltd Urea compound for antagonizing lpa1 receptor
EP4058144A1 (en) 2019-11-15 2022-09-21 Gilead Sciences, Inc. Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
TWI843503B (zh) 2020-06-03 2024-05-21 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
EP4161936A1 (en) 2020-06-03 2023-04-12 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
CN111909170B (zh) * 2020-09-11 2022-08-12 吉林奥来德光电材料股份有限公司 一种有机电致发光化合物、其制备方法以及包含该有机电致发光化合物的有机电致发光器件
JP2022115836A (ja) * 2021-01-28 2022-08-09 大正製薬株式会社 Lpa1受容体を拮抗するウレア化合物を有効成分として含有する医薬
WO2022240879A1 (en) 2021-05-11 2022-11-17 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
KR20240007233A (ko) 2021-05-13 2024-01-16 길리애드 사이언시즈, 인코포레이티드 Lpa 수용체 길항제 및 이의 용도
WO2023107938A1 (en) 2021-12-08 2023-06-15 Gilead Sciences, Inc. Lpa receptor antagonists and uses thereof
US12180414B2 (en) 2022-12-12 2024-12-31 Bmic Llc Downstream uses for briquettes and other forms of powder from asphalt shingle waste

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1258484E (pt) * 2000-02-18 2009-04-03 Kyowa Hakko Kirin Co Ltd Novos compostos de isoxazol e de tiazol e sua utilização enquanto fármacos
WO2002062389A1 (en) 2001-02-08 2002-08-15 Ono Pharmaceutical Co., Ltd. Remedies for urinary diseases comprising lpa receptor controlling agents
JP4692281B2 (ja) * 2003-08-05 2011-06-01 味の素株式会社 新規アゾール化合物
CA2738878C (en) 2008-09-29 2013-08-13 Eli Lilly And Company Selective estrogen receptor modulator for the treatment of osteoarthritis
GB2466121B (en) * 2008-12-15 2010-12-08 Amira Pharmaceuticals Inc Antagonists of lysophosphatidic acid receptors
GB2470833B (en) 2009-06-03 2011-06-01 Amira Pharmaceuticals Inc Polycyclic antagonists of lysophosphatidic acid receptors
CN102574822A (zh) 2009-08-04 2012-07-11 阿米拉制药公司 作为溶血磷脂酸受体拮抗剂的化合物
GB2474748B (en) 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
GB2474120B (en) 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
WO2011091167A2 (en) 2010-01-22 2011-07-28 The General Hospital Corporation Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases
WO2011159635A1 (en) 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions
WO2011159633A1 (en) 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Inhalable formulations of lysophosphatdic acid receptor antagonists
WO2011159632A1 (en) 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
KR20130126659A (ko) * 2010-12-07 2013-11-20 아미라 파마슈티칼스 인코포레이티드 리소포스파티드산 수용체 길항제 및 섬유증 치료에서의 그의 용도
DK2648726T3 (da) 2010-12-07 2018-07-16 Amira Pharmaceuticals Inc Polycyklisk lpa1-antagonist og anvendelser deraf
WO2012138797A1 (en) * 2011-04-05 2012-10-11 Amira Pharmaceuticals, Inc. 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
WO2012138648A1 (en) 2011-04-06 2012-10-11 Irm Llc Compositions and methods for modulating lpa receptors
JP2014525932A (ja) 2011-08-15 2014-10-02 インターミューン, インコーポレイテッド リゾホスファチド酸レセプターアンタゴニスト
KR102189166B1 (ko) * 2012-12-28 2020-12-09 우베 고산 가부시키가이샤 할로겐 치환 헤테로환 화합물

Similar Documents

Publication Publication Date Title
JP2017214410A5 (https=)
JP2016153424A5 (https=)
CL2014000270A1 (es) Compuestos derivados de 3,5-difenil diazoles sustituidos, inhibidores de la agregacion de proteinas. (divisional de la solicitud n° 1369-2010).
EP4045363A4 (en) BEHAVIORS THAT REDUCE DEMAND FOR AUTONOMOUS FOLLOWING VEHICLES
JP2013539454A5 (https=)
CY1122617T1 (el) Απαλλαγμενες prion συνθεσεις νανοσωματιδιων και μεθοδοι
JP2018024670A5 (https=)
JP2009004351A5 (https=)
EP2951579A4 (en) METHODS, SYSTEMS AND SOFTWARE FOR DETECTING BIOMOLECULES USING MODELS OF MULTIPLICATIVE FORM
JP2009530282A5 (https=)
JP2010501534A5 (https=)
JP2017048194A5 (https=)
EA201170227A1 (ru) Имидазолкарбоксамиды
JP2009091351A5 (https=)
JP2018116258A5 (https=)
JP2013500371A5 (https=)
NO20082837L (no) Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner
JP2010241791A5 (https=)
JP2015199738A5 (https=)
JP2021532774A5 (https=)
DK3402781T5 (da) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater
CL2021000375S1 (es) Contenedor. (divisional solicitud 202000650)
JP2010243737A5 (https=)
JP2017042232A5 (https=)
JP2011059293A5 (https=)